Back
ResMed, Inc. 10K Form
Buy
68
RSMDF
ResMed, Inc.
Last Price:
$27.25
Seasonality Move:
5.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10K | RSMDF/ResMed, Inc. Annual |
| 2020-05-01 | 10Q | RSMDF/ResMed, Inc. Quarterly |
| 2020-01-31 | 10Q | RSMDF/ResMed, Inc. Quarterly |
| 2019-10-25 | 10Q | RSMDF/ResMed, Inc. Quarterly |
| 2019-08-08 | 10K | RSMDF/ResMed, Inc. Annual |
| 2019-05-03 | 10Q | RSMDF/ResMed, Inc. Quarterly |
Receive RSMDF News And Ratings
See the #1 stock for the next 7 days that we like better than RSMDF
RSMDF Financial Statistics
Sales & Book Value
| Annual Sales: | $5.1B |
|---|---|
| Cash Flow: | $411.5M |
| Price / Cash Flow: | 22.56 |
| Annual Sales: | $4.19 |
| Price / Book: | 6.52 |
Profitability
| EPS (TTM): | 0.97720 |
|---|---|
| Net Income (TTM): | $1.4B |
| Gross Margin: | $3B |
| Return on Equity: | 25.6% |
| Return on Assets: | 18.72% |
ResMed, Inc. Earnings Forecast
Key ResMed, Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for RSMDF is 58.48%.
-
The Selling, General & Administrative Expenses for RSMDF have been equal to 19.26% of Gross Profit Margin.
-
The Research & Development expenses have been 6.44% of Revenue.
-
The Interest Expense is 0.90% of Operating Income.
-
The Net Earning history of RSMDF is 27.22% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 26 years.
ResMed, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RSMDF |
| Website: | resmed.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.89 |
| Quick Ratio: | 1.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.66 |
|---|---|
| Forward P/E Ratio: | 0 |
RSMDF Technical Analysis vs Fundamental Analysis
Buy
68
ResMed, Inc. (RSMDF)
is a Buy
Is ResMed, Inc. a Buy or a Sell?
-
ResMed, Inc. stock is rated a BuyThe current ResMed, Inc. [RSMDF] share price is $27.25. The Score for RSMDF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.